Matthew Pauls Insider Trading $SVRA Savara Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew Pauls.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew Pauls. Matthew Pauls is CHIEF EXECUTIVE OFFICER in Savara Inc ($SVRA) and Director in Mast Therapeutics, Inc. ($MSTX) and See Remarks in Savara Inc ($SVRA) and Director in Egalet Corp ($EGLT) and President & CEO in Strongbridge Biopharma plc ($SBBP).
Matthew Pauls in Savara Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew Pauls: CHIEF EXECUTIVE OFFICER, See Remarks, Director
Holdings: 308,122 shares
Current Value: $43,137
Latest Transaction: Apr 19 2021
$SVRA Market Capitalization: $32.99M
$SVRA Previous Close: $0.14
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Matthew Pauls in Savara Inc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, SVRA, SBBP, EGLT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19 2021 | SVRA | Savara Inc | Pauls Matthew | CHIEF EXECUTIVE OFF ... | Buy | P | 1.82 | 27,400 | 49,871 | 308,122 | 280.7 K to 308.1 K (+9.76 %) |
| Mar 22 2021 | SVRA | Savara Inc | Pauls Matthew | CHIEF EXECUTIVE OFF ... | Buy | P | 2.07 | 24,100 | 49,938 | 280,722 | 256.6 K to 280.7 K (+9.39 %) |
| Mar 22 2021 | SVRA | Savara Inc | Pauls Matthew | CHIEF EXECUTIVE OFF ... | Buy | P | 2.07 | 24,100 | 49,938 | 280,722 | 256.6 K to 280.7 K (+9.39 %) |
| Feb 23 2021 | SVRA | Savara Inc | Pauls Matthew | CHIEF EXECUTIVE OFF ... | Buy | P | 1.74 | 28,700 | 50,038 | 256,622 | 227.9 K to 256.6 K (+12.59 %) |
| Dec 17 2020 | SVRA | Savara Inc | Pauls Matthew | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.23 | 500,000 | 615,000 | 500,000 | |
| Sep 15 2020 | SVRA | Savara Inc | Pauls Matthew | See Remarks | Option Exercise | A | 1.32 | 898,639 | 1,186,203 | 898,639 | |
| Sep 15 2020 | SVRA | Savara Inc | Pauls Matthew | See Remarks | Option Exercise | M | 0.00 | 650 | 0 | 0 | |
| Sep 15 2020 | SVRA | Savara Inc | Pauls Matthew | See Remarks | Grant | A | 0.00 | 227,272 | 0 | 227,922 | 650 to 227.9 K (+34,964.92 %) |
| Sep 15 2020 | SVRA | Savara Inc | Pauls Matthew | See Remarks | Buy | M | 0.00 | 650 | 0 | 650 | 0 to 650 |
| Dec 26 2019 | SVRA | Savara Inc | Pauls Matthew | Director | Option Exercise | A | 1.59 | 12,000 | 19,080 | 12,000 | |
| Dec 14 2018 | SVRA | Savara Inc | Pauls Matthew | Director | Option Exercise | A | 7.33 | 12,000 | 87,960 | 12,000 | |
| May 26 2017 | MSTX | Savara Inc | Pauls Matthew | Director | Option Exercise | A | 5.13 | 3,750 | 19,238 | 3,750 | |
| Jan 23 2017 | MSTX | Mast Therapeutics, ... | Pauls Matthew | Director | Option Exercise | A | 0.00 | 45,535 | 0 | 45,535 | |
| Jun 17 2016 | MSTX | Mast Therapeutics, ... | Pauls Matthew | Director | Option Exercise | A | 0.43 | 79,551 | 34,207 | 79,551 | |
| Nov 02 2015 | MSTX | Mast Therapeutics, ... | Pauls Matthew | Director | Option Exercise | A | 0.48 | 37,794 | 18,141 | 37,794 | |
| Nov 02 2015 | MSTX | Mast Therapeutics, ... | Pauls Matthew | Director | Option Exercise | A | 0.48 | 64,791 | 31,100 | 64,791 |
Page: 1